SPYRE THERAPEUTICS INC

Ticker: SYRE CUSIP: 00773J202 Class: Common Stock

DRIEHAUS CAPITAL MANAGEMENT LLC's Holding History (CIK: 0000938206)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 2,882,420 Value ($000) $94,428 Avg Close $26.13 Range $15.86 - $35.31
Q3 2025
Shares 2,060,375 Value ($000) $34,532 Avg Close $16.31 Range $14.00 - $18.30
Q2 2025
Shares 2,085,590 Value ($000) $31,221 Avg Close $14.80 Range $10.91 - $19.20
Q1 2025
Shares 2,717,312 Value ($000) $43,844 Avg Close $20.81 Range $16.13 - $26.01
Q4 2024
Shares 2,803,655 Value ($000) $65,269 Avg Close $29.32 Range $22.37 - $40.26
Q3 2024
Shares 687,080 Value ($000) $20,207 Avg Close $27.85 Range $23.00 - $32.41
Q2 2024
Shares 687,080 Value ($000) $16,153 Avg Close $33.73 Range $22.19 - $40.84
Q1 2024
Shares 687,080 Value ($000) $26,061 Avg Close $28.97 Range $18.54 - $47.97
Q4 2023
Shares 771,902 Value ($000) $16,611 Avg Close $13.78 Range $8.43 - $22.66
Q3 2023
Shares 800,853 Value ($000) $9,810 Avg Close $13.22 Range $9.53 - $18.00